17 February 2018
News and Views
Links and Services
A study in the latest Inflammatory Bowel Disease correlates retrieval of serum infliximab level by shortening the maintenance infusion interval with clinical efficacy in Crohn's disease.
Infliximab has shown beneficial effects in the treatment of Crohn's disease (CD).
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors